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ABSTRACT
Isotopes from the lanthanide series are suitable for intense localized radiotherapy of
tumors and melanomas. 166Ho is a promising radioisotope for use in medical radiotherapy
due to its relatively short half-life of 26.8 hours and emission of high-energy β-particles.
166Ho can be produced in suitable quantities using the USGS 1 MW TRIGA reactor located
at the Denver Federal Center. A prototype patch was created by RF sputtering holmium
oxide onto Kapton foil. The prototype patch showed that β-particles have good penetration
and rapid fall-off in the photographic paper. A few short comings were observed in the
prototype holmium radiotherapy patch. The current RF sputtering process is slow and non-
uniform. This may be due to using a holmium oxide target instead of a holmium metal target.
Delamination was observed in some of the prototype patches. A design that contains the
holmium deposition will be necessary. The activity and the presence of contaminants were
analyzed using γ-spectra dominated by an 80.6 keV γ-ray. Irradiation and measurements of
a holmium oxide radiotherapy patch that was sputtered for 1 h at 150 W show an activity
of 7.03 ± 0.35 µCi. Error is largely due to the error in the calibrated sources as well as
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Radiotherapy is a common method of skin cancer treatment. Radioactive sources will
emit radiation in the form of γ-rays, β-particles, and x-rays which cause damage when they
collide with tissue, in this case skin. In the case of skin cancer, the radiation would impact
the cancer cells killing the unwanted skin cells and then letting new healthy skin cells grow
in their place. The hope is that the benefits of external irradiation can be harnessed into a
form that will damage only the cancerous cells and not the healthy surrounding tissue. In
this case, a radioactive skin patch will be developed for the treatment of non-melanoma skin
cancers.
1.1 166Ho Skin Patch Proposal
The feasibility of producing a 166Ho patch in a reactor located near a hospital is being
looked into for the radiotherapy of some cancers. The radioactive skin patch produced would
be used for the treatment of non-melanoma skin cancers, such as basal cell carcinoma (BCC)
and squamous cell carinoma (SCC). The patch will be designed to have an area that is the
same size and shape as the lesion in which the radioisotope would be located. The hope
is that the radiotherapy would then be confined to the cancerous lesion and the healthy
skin cells would be minimally affected. The radiotherapy platform for the experiment will
be Kapton foil. The Kapton foil will be sputtered with holmium oxide Ho2O3 using an RF
sputterer. The reasons for using Kapton foil and RF sputtering will be discussed in sections
2.3 and 4.1 respectively. The patch will then be irradiated in a reactor. 165Ho will be turned
into 166Ho by an (n, γ) reaction which then decays via β−-decay to 166Er which is stable.
Due to the half-life of 166Ho (discussed further in 2.1), the irradiation facility will need to
be located nearby. In this case, the reactor used for the irradiations will be the TRIGA
reactor located at the USGS site at the Federal Center in Denver, Colorado. This reactor is
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in close proximity to a variety of hospitals, so if the patch production is shown to work at
the Federal Center, it could potentially be used in the future for actual cancer therapy at
nearby hospitals. Due to the dangerous nature of any radioactive sources, the process will
need to be controlled and the activity accurately predicted. This ensures the safety of those
performing the patch production and the measurements as well as the safety of the patients
and doctors eventually employing the radiotherapy. This experiment attempts to show that
it is possible to safely produce the patch with a predictable activity. Eventually, it is hoped
that the method can be extrapolated to other elements in the lanthanide series and possibly
other elements with similar properties discussed in 2.1. The advantages of this therapy could
be enormous. The radioisotope therapy would be made specifically for each patient, so the
patch fits the size of each lesion. The need for new costly equipment would be bypassed by
the fact that the therapy would be using equipment and facilities already in place, such as
the USGS reactor. The therapy has the potential to decay away quickly leaving the hospital
with minimal radioactive waste, which is difficult and expensive to dispose. The focus of
this thesis is the production of 166Ho from 165Ho for the use in medical application, in order
to prove that it is possible to make the skin patches using Kapton tape and sputtering
techniques with predictable activities.
1.2 Skin Cancer
The most common human malignancy is skin cancer [1]. Over 95 % of new cases of
non-melanoma skin cancer are basal cell carcinoma (BCC) and squamous cell carcinoma
(SCC). 95 % of BCC cases occur in patients over 40 years of age [2]. BCC used to be found
almost entirely in middle-aged or older people, but recently, the occurrences in young people
have become much more common, presumably due to an increase in sun exposure [3]. BCC
and SCC most often occur on the areas of skin that have been exposed to the sun such
as the face, ears, neck, and back of the hands [4]. The occurrence of skin cancer has been
increasing over the years due to the increased life span in many countries, and it is estimated
that more than 1.3 million non-melanoma skin cancers will develop annually in the US [5].
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The commonality of skin cancer has catalyzed research into looking for a more effective and
economical, as well as more comfortable and less time consuming for the patient method
for radiotherapy. Non-melanoma skin cancers are known to be treatable, and if treated in
a timely and thorough manner, SCC or BCC becoming malignant skin cancer is almost
completely preventable.
1.3 Current Treatment Methods
The current methods of treatment include surgical management, chemotherapeutic agents,
radiotherapy, and photodynamic therapy [1].
Curative procedures like excisional surgery are currently the most common surgical
method of treating skin cancer [6]. The advantages of excision lay largely in the fact that the
whole legion can be removed for histological analysis and can provide a cure rate for small,
low-risk BCC and SCC [7] of 95 %. The recurrence rate of Bowen’s disease (non-invasive
SCC) that is large and dispersed across the body is 20 % [6]. The major disadvantage of
surgical excision is the presence of the malignancies in areas which are difficult to do surgery
on - the eyelids, nose, and lips. The need for skin grafts on the excised region also adds
to the difficulty of excising certain malignancies. Methods of surgery such as curettage and
cautery can be 81-93 % effective, but also has a 4-year recurrence rate of 36 % [8]. Major
limitations to curettage and cautery occur because the lesions are fragmented, SCC can-
not be completely excluded for premalignant lesions such as AK (actinic keratosis which is
a lesion that may turn into SCC but is not yet considered cancerous) or Bowen’s disease.
Curettage requires local anesthesia and may cause scar formation and wounds are susceptible
to infection [9]. Mohs’ micrographic surgery (MMS) has a success rate of 99-100 % and a
5-year recurrence rate of 2.1 % [10]. However, MMS is time consuming, operator dependent,
and quite costly. MMS is usually only recommended for high-risk patients [1].
Chemotherapy has a good success rate, but the diverse and severe side effects make it
undesirable for treatment of skin cancer. Currently, the FDA has approved the usage of
topical chemotherapy treatments, but can result in many side effects such as local irritation,
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erythema, painful swelling, pruritus, dyspigmentation, and photosensitivity [11]. Topical
chemotherapy can have upwards of a 92 % cure rate, however, many treatment regiments
involve once to twice daily applications for a period anywhere from 1 week to 2 months
(sometimes longer) [8].
There is also a form of radiotherapy available for treatment. Radiotherapy from high-
energy x-rays cause cell death by damaging the cell’s DNA either directly of indirectly via
oxygen-free radicals [1]. External radiotherapy for skin cancer consists of bombarding the
malignancy with x-rays. Although this can be quite effective, there are disadvantages to
this therapy as well. Disadvantages include expense due to need for special equipment for
therapy, the patient receives fractionated therapy, and underlying organ can be irritated
or harmed. If a particular area has received the full tumor dose it cannot be irradiated a
second time, and chronic irradiation dermatitis can develop over time. Decreased cosmetic
effect may also occur after long periods of time. Some studies show that 15 years after
radiotherapy/surgery for BCC, the percentage of radiation patients who had either excellent
or good cosmetic results decreased by 20 % [12].
Other forms of therapy such as PDT (photodynamic therapy) also present similar prob-
lems as radiotherapy and chemotherapy. Therapy is fractionated, expensive due to extremely
specialized equipment, and many and various side effects are encountered.
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CHAPTER 2
166HO SKIN PATCH AS A TREATMENT OPTION
The current skin cancer treatment methods are expensive, time consuming, and have a
variation of adverse side effects associated with the treatment method. Recently, β-emitting
isotopes have caught the attention of researchers as a possible alternative to the current
skin cancer treatment option. Successful animal and human trials have been done using
β-emitters, and the success of 166Ho skin patches has been especially promising due to its
physical and chemical reactivity properties.
2.1 β-Emitters and Holmium
The superficial administration of radioisotopes to melanomas can destroy the malignan-
cies without patients needing surgery. Due to the disadvantages of current radiotherapy,
interest in β−-particle (here after referred to as β-particles) radiation therapy has grown.
Advantages to β-particle radiation include a high linear transfer as well as a rapid fall off
[1]. High linear transfer refers to the β-particle losing energy quickly due to its interactions,
meaning its energy is deposited quickly in the skin and does not penetrate deep into the skin
and underlying tissue. Most SCC and BCC malignancies that penetrate thicknesses of at
least 2 mm need extensive therapy to prevent remission. β-particles penetrate on average 2
mm into tissue [13] allowing for localized therapy to the malignancy while sparing underlying
tissue and bone. Rapid fall-off means that the β-particles will retain the size and shape of
their source, they do not spread out over a large area. The radioisotopes would be used for
localized cancer treatment (tumors, melanomas). The containment of β-particles prevents
the skin around the treatment area being damaged. β-particle radiation treatment does not
need to be fractionated, and up front expenses are less than current radiotherapy because
there need not be special equipment to administer therapy. A half-life on the order of a
day allows for the patch to be disposed of fairly quickly after use. In turn, however, the
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patch will need to be used quickly after its irradiation in order for the patch to be effective.
Day half-lives allow enough time for transitions between preparation of the Kapton therapy
platform and administration of the therapy without decaying significantly. The isotope does
not need a long irradiation time to reach the required activities. The dosage used in [1] was
35-50 Gy. A 10 mg sample of 165Ho irradiated for about 1 hour at a TRIGA reactor (thermal
neutron flux of 3 · 1012) will give a sufficient activity to administer this dose to a typical 1
cm2 area.
Lanthanides such as 141Ce, 165Dy, 169Er, and 166Ho possess many of the advantages looked
for in a β-emitting radioisotope for radiotherapy. The emitted radiation is generally low-
energy γ-rays and β-particles with energies on the order of a few MeV. The energies of the
γ-rays emitted need to be low to avoid deep penetration in the patient which could cause
damage to surrounding tissue. The β-particles do not penetrate deep into body tissue so
high-energy β-particles are needed to destroy the skin disease. In the lanthanide series, a
few γ-rays of high energy may be emitted and some x-rays are produced, but high-energy
γ-rays are emitted with very low intensity and x-rays are emitted with very low energy in
the lanthanide series. The radioisotopes of interest ideally should have a half-life on the
order of a day, which is found in the lanthanides mentioned above. Finally, elements from
the lanthanide series are chemically safe to humans in reasonable quantities.
The radioisotope 166Ho meets the desired criteria for a reactor-to-patient medical ra-
dioisotope. To begin with, it meets the half-life and toxicity requirements; it is also fairly
unreactive. 166Ho has a half-life of 26.8 hours and is chemically safe to humans. It often
comes in in a chemically stable oxide form (Ho2O3).
166Ho mostly β-decays to two energy
levels of 166Er (which is stable). The β-particles emitted by 166Ho have maximum energies
of 1854.7 keV with an intensity of 48.8 β’s per 100 decays and 1773.1 keV with intensity
of 49.9 β’s per 100 decays as seen in Figure 2.1 [14]. The 1.85 MeV β-decay goes directly
to the ground state of 166Er. The 1.77 MeV β-decay goes to the 80.5775 keV energy level
[14]. The excited state of 166Er can decay to the ground level either through the emission
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of γ-rays or through the emission of x-rays. This is due to internal conversion. The 80.5775
keV γ-ray will be emitted with a total intensity of 6.56 decays per every 100 decays [14].
A variety of x-rays may be emitted due to internal conversion from the 80.5775 keV energy
level, but these are, at the highest, 60 keV. High energy γ-rays may be emitted from the
production and decay of the metastable state of 166Ho (denoted as 166Hom). The calculation
of dose caused by 166Hom is done later. The half-life of 166Hom is 1200 y. As long as 166Hom
is not produced in significant quantities, its influence is completely negligible. The γ-rays
and x-rays are of sufficiently low energy that there is no deep penetration. Future work
may consider these forms of radiation as a secondary source for treatment. The 80.5775 keV
comprises 100 % of the γ-rays emitted by the 1.77 MeV β-decay of 166Ho. This allows the
γ-ray at 80.6 keV to be used for the determination of the absolute activity of the sample.
The x-rays that are emitted will be used in the dosage calculations and the comparison of
the radiation field measurement made by the USGS.
Figure 2.1: 166Ho ground state decay scheme.
In addition to the appropriate half-life and decay properties, 165Ho has a large thermal
neutron capture cross-section of approximately 60 b. According to the ENDF VII files, the
total cross-section of 165Ho as it depends on energy is seen in Figure 2.2.
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Figure 2.2: The total cross-section of 165Ho is plotted from the ENDFVII library [15].
It can be seen that the approximate 165Ho neutron capture cross-section is around 60 b.
These results are compared with the thermal energy neutron capture cross-sections of 165Ho
seen in Figure 2.3.
It can be seen that the absorption cross-section is quite high at thermal energies. Around
0.025 eV, the absorption cross-section of holmium is around 60 b, which is consistent with
the files generated from the ENDF VII database. These files both agree with the data from
the USGS TRIGA reactor which has more detailed neutron cross-sections. According to
the tables available at the TRIGA reactor [17], the thermal neutron and fast neutron cross-
sections pertain when 165Ho is placed in the TRIGA reactor at the Federal Center as shown
in table Table 2.1.
The cross-sections apart from the thermal neutron capture cross-section of 165Ho are negli-
gible. 165Ho will only produce 166Hog in any significant quantity. The other cross-sections
are so small and the irradiation times short that the production of other isotopes is highly
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Figure 2.3: The total cross-section of 165Ho is denoted by the open circles; the nuclear
absorption, paramagnetic scattering, and nuclear scattering are denoted by σa, σpm, and
σs. The cross-sections are for the thermal energy range [16].
Table 2.1: Neutron absorption cross-sections of 165Ho in the USGS TRIGA reactor [17]
Reaction Activated Isotope Cross-section
Slow reactor neutrons
(n,γ) 166Hom 3.5 ± 0.5 b
(n,γ) 166Hog 63 ± 3.3 b
(n,γ) 166Hom+g 66.5 ± 3.3 b
Fast reactor neutrons
(n,p) 165Dym+g 4 (+6, -2.5) µb
(n,α) 162Tb 0.6 (+0.5, -0.3) µb
(n,2n) 164Hom+g 3.9 (+2.7, -1.6) mb
unlikely and will not occur in any harmful quantity. 166Hom production will be very small,
because of its small neutron capture cross-section. The effects from it will be completely neg-
ligible due to the small cross-section combined with its very long half-life. The cross-sections
from the USGS TRIGA reactor were used for predicting the activity, because they are more
precise than the numbers available in the other sources and the USGS TRIGA facility trusts
the cross-sections as accurate. They also are validated by the ENDF VII measurements and
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estimates and the measurements made in [16]. As has been mentioned, it is important to
accurately predict the activity for the safety of those producing the holmium patch as well
as avoiding long cool down times due to a holmium radiotherapy patch having too high of
an activity for therapy, which means an accurate production rate must be known.
2.2 Prior Research
Successful research and experiments have been performed with β-emitting sources. 188Re
was used for tumor therapy in mice [18]. 188Re has a 2.1 MeV β-particle and emits a 155
keV γ-ray at 15 % intensity. In Preparation of 188Re-labeled paper for treating skin cancer
[18], a 74 MBq 188Re-labeled paper with a 1 cm diameter delivered up to 147.2 Gy to a
depth of 1 mm in a 2 hr irradiation. The dose from the γ-ray was negligible when compared
to the β-particle dose. The test subjects with SCC showed complete remission in 2/3 of
the populace with a 50 Gy dose and 4/5 of the populace with a 100 Gy dose [18]. This
is compared with the progressive growths of tumors found in all control mice which were
not treated with the radiotherapy. At much higher doses than 100 Gy, the benefits of the
therapy were negligible when compared to the side effects. Rashes were found in all mice
treated with 200 Gy as compared with 3/8 of the 100 Gy treated mice [18]. One mouse was
treated with 900 Gy and showed necrosis on the 7th day after treatment and a scar on the
70th day after treatment. Results were quite good with the remission of the skin cancer seen
with the 50 to 100 Gy dose. At higher dose rates, there were side effects seen in the mice
that are undesirable for cancer treatment due to their severity and discomfort.
There have also been successful human trials in South Korea using a 166Ho patch of 35
Gy for Bowen’s disease cases and 50 Gy for SCC and BCC which were applied 30 minutes
to an hour on patients [1]. In Figure 2.4 and Figure 2.5, some successfully treated skin
malignancies using the 166Ho patch are seen.
In cases with tumors, tumors with less than a 3 mm thickness could be cured in a single
therapy session according to [1]. For deeper tumors, either a longer duration for application
of the therapy is required or fractionated therapy is needed which is one the treatment steps
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Figure 2.4: Basal cell carcinoma treated with 50 Gy 166Ho patch. Clearance of skin disease
seen 7 days after application of patch [1].
Figure 2.5: Bowen’s disease treated with 35 Gy 166Ho patch. Clearance of skin disease seen
7 days after application of patch [1].
hoping to be avoided [1]. Bowen’s disease patients who were treated with the 166Ho patch
showed no recurrence of Bowen’s disease when surveyed one and two years after treatment
[19], which is a quite promising result.
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An important aspect of the β-particle radiotherapy is that the energy from the radiation
is mostly deposited in cancerous tissue instead of healthy tissue. VARSKIN3 code was
used to simulate the skin dose provided from the 166Ho source in Depth dose calculation of
Holmium-166 for different shape source by VARSKIN3 code [13]. They used a default value
of 10 cm2 for the average skin area and 60 minutes for exposure time with a 1 µCi source.
Figure 2.6: The depth dose as found using the VARSKIN3 code showing the normalized
absorbed rate with respect to the depth of skin of a 166Ho source [13, 20].
Figure 2.6 is taken from the Depth dose calculation of Holmium-166 for different shape
source by VARSKIN3 code. The source shape used for the results in Figure 2.6 was slab
shaped. The slab-shaped source is similar to what the shape of the holmium patch will be,
however, the thickness used in this program was 1000 µm. The advantage of the 166Ho can
be seen by the high linear energy transfer or rapid depth dose fall as seen in the depth-dose
plot. The dose is absorbed largely in the first 3 mm of skin that the β-particles interact
with.
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2.3 A Candidate for the 166Ho Skin Patch Substrate
Kapton is a polyimide film. It can be adhesive coated (which is potentially important
for medical application [21]). The chemical formula for Kapton is C22H10N2O5 [22]. Kapton
is ideal for radiotherapy applications, because it can be irradiated and will produce few
unstable isotopes due to being comprised of light elements which have low neutron capture
cross-sections and multiple stable isotopes. Kapton is also able to maintain its physical,
electrical, and mechanical properties over a wide temperature range which allows it to be
irradiated without being damaged in the high temperatures of a reactor [21].
For the therapy platform in this work, the Kapton film will be sputtered with Ho2O3.
This will be done using RF sputtering. Thermal evaporation was not considered due to the
high melting point of holmium oxide. Argon gas and oxygen gas will be used to sputter the
holmium oxide in a 9:1 ratio. Although it is possible to use only argon gas for sputtering
the holmium oxide, this may produce an oxygen deficient deposition layer. If the layer is
significantly low in oxygen, this could affect the determination of how much holmium has
been deposited. It could cause the calculation of the number of holmium atoms on the
Kapton foil to be lower than it really is, meaning a higher activity would be produced than
expected. This should be avoided, so sputtering with oxygen ensures that the holmium oxide
deposition is not oxygen deficient.
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CHAPTER 3
MEASUREMENTS AT THE TRIGA REACTOR
All the irradiations for these experiments were done at the USGS TRIGA reactor located
in the Denver Federal Center. The resulting samples’ activities were measured using an HPGe
detector that is located in lab room 110 in the reactor building. The photographic exposures
which are not discussed in this section were done in lab room 114 of the reactor building.
3.1 USGS TRIGA Reactor
The TRIGA reactor is a low-enriched uranium-fueled, pool-type reactor. The samples
were all irradiated during steady-state operations of the TRIGA reactor. The steady-state
power level is 1000 kW. The reactor has a number of tubes (dry and wet) which can be
used to place samples in or around the reactor core in order to subject the sample to a high
neutron flux. The two regions most commonly used for irradiation are the central thimble
and the lazy Susan. A picture of the reactor core can be seen in Figure 3.1.
The central thimble is a water-filled tube that leads to the center of the reactor. The neutron
flux is highest in the central thimble, the maximum thermal flux in the central thimble is
on the order of 3 · 1013 n
s · cm2 . The lazy Susan is a rotary specimen rack that is outside the
reactor core and inside the graphite reflector of the reactor. It has 40 positions available
for sample irradiations and it rotates around the core. The lazy Susan is a dry facility and
the maximum thermal neutron flux in the lazy Susan is on the order of 3 · 1012 n
s · cm2 . The
lazy Susan is far enough away from the reactor core that there is very little fast neutron
flux. The samples for these experiments were done in the lazy Susan, so it is necessary to
have a more exact neutron flux spectra. In the fall of 2013, neutron flux calculations were
done for the lazy Susan at the USGS TRIGA reactor. To find the neutron flux, aluminum
foils with 0.1143 wt% gold were irradiated in the lazy Susan and the resulting γ activity was
analyzed. 197Au is 100 % natural abundance. It has a thermal neutron capture cross-section
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Figure 3.1: A picture of the USGS 1 MW TRIGA reactor core is shown with the relevant
irradiation zones denoted.
of 98.8 b and a fast neutron capture of 0.04 b (negligible when compared to the thermal
capture cross-section). 198Au has a half-life of 2.69 d, whereas aluminum has a half-life of 2.3
min, so the γ measurements were taken after the aluminum had decayed. 198Au emits only
one γ-ray at 411.8 keV and is emitted with 98.99 % intensity. The gold foils were placed in
a polyethylene tube by cutting slits into the tube and placing the foil in the tube. When
the experiment was done, the tube was wrapped in borated aluminum which reduces the
thermal neutron flux to about 30.1 % of the flux within the lazy Susan which is seen by a
comparison with samples that did not have the borated aluminum surrounding them. The
purpose for the borated aluminum was to see how well it absorbed the incoming neutrons,
since the borated aluminum had an unknown composition. The polyethylene tube keeps the
gold foils in place so that the neutron flux can be determined by the position relative to the
top of the reactor core. The foil mass and gold mass, the associated positions, the resulting
activity, and the neutron flux are shown in Table 3.1. The errors all round to 1 · 109 n
cm2 · s .
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7.278 0.00832 0.30 0.775 1.281
7.466 0.00853 1.10 0.767 1.236
7.486 0.00856 1.95 0.787 1.265
7.136 0.00816 2.75 0.697 1.175
7.423 0.00848 3.50 0.699 1.133
7.372 0.00843 4.25 0.657 1.072
8.058 0.00921 5.05 0.702 1.048
7.351 0.00840 5.80 0.608 0.995
7.330 0.00837 6.50 0.580 0.953
The neutron flux is already appearing to be on the same order of magnitude as the maximum
neutron flux in the lazy susan should be. The flux can be seen with its dependence on position
in Figure 3.2.
Figure 3.2: The neutron flux as it depends on the vertical position of the sample. The
bottom of the lazy Susan is considered to be 0 mm.
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The neutron flux decreases closer to the top of the reactor core and is highest at the bottom
of the lazy susan. The holmium samples were placed between 2 and 3 cm from the bottom
of the core. Since this flux is for samples with borated aluminum wrapped around them
and the holmium patch samples will not be wrapped in borated aluminum, these must be
compared to flux measurements taken by Ali Jason Fathi. The masses and irradiation time
are unknown for these numbers, but the measured activity and the calculated neutron flux
are given in Table 3.2.
Table 3.2: The neutron flux is shown with respect to the position from the bottom of the
core [24].















The considerable increase in flux without the borated aluminum can be seen. This is the
flux that will be used for the experiment, but since these calculations were done by a third
party, it was important to check them against the neutron flux calculations in Table 3.1.
Applying a line of best fit to the data in Table 3.1 and Table 3.2, gives the following
relations in equations 3.1 and 3.2 with an R2 of 0.963 and 0.968 respectively.
φ(z) = 1 · 1012 − 6 · 1010z (3.1)
φ(z) = 4 · 1012 − 1 · 1011z (3.2)
Comparing the neutron flux in Figure 3.3 to the neutron flux in Figure 3.2 shows that the
borated aluminum on average decreases the neutron flux on the samples to about 30.1 % as
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Figure 3.3: The neutron flux as it depends on the vertical position of the sample. The
bottom of the lazy Susan shows is considered to be 0 mm.
discussed previously.
3.2 HPGe Detector with Beryllium Window for γ-Ray Measurements
An HPGe detector is used for γ-ray measurements. The γ-spectra allow the activity of the
samples to be calculated. An energy calibration is done in order to determine what energy
a bin represents. The HPGe’s relative and geometric efficiencies must also be calibrated in
order to find absolute activities of the samples.
3.2.1 Experimental Setup
The detector being used for γ-ray measurements is an High-Purity Germanium (HPGe)
detector with a 0.5 mm beryllium window on the end of the detector. The purpose of the
beryllium window is to seal the germanium crystal from the air while allowing low energy x-
rays and γ-rays to pass through to the detector crystal without significant attenuation. The
HPGe detector is a GMX series coaxial photon detector from ORTEC as seen in Figure 3.4.
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Figure 3.4: The detector in the lab can be seen.
It has a crystal diameter of 49.9 mm, a crystal length of 58.3 mm, a plastic end cap of 3 mm,
and the beryllium window as mentioned before. There is an inactive germanium section of
0.3 mm. This refers to the thickness of germanium that doping did not reach during the
quenching and annealing process of the crystal’s manufacturing. The section of inactive
germanium is another part of the detector setup that can absorb photons without sending a
signal to the electronics. The HPGe crystal is cooled with liquid nitrogen. The crystal must
remain cool in order to keep the energy band gap of the germanium larger than what it is
at room temperature. At room temperature the energy band gap of germanium is 0.67 eV.
This band gap is so small that electrons at room temperature can easily pass between the
valence and conduction bands. Noise is then produced, and it is difficult to distinguish energy
peaks with good resolution. By cooling the crystal, the electrons have much less energy and
cannot move across the energy gap. They must be excited by actual incoming radiation
like γ-rays and x-rays before they can move from the valence band to the conduction band,
which significantly reduces noise. The HPGe detector setup need a high voltage supply. This
detector is currently at 3000 V. High voltage allows for better energy resolution. Applying a
voltage to a detector causes a depletion zone to form in the crystal, which is an area where
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the mobile charge carriers have diffused away. The reverse bias of the HPGe detector allows
free flow of the current in one direction. The current is directly proportional to the energy
of the incoming particle. The amplifier takes the incoming current and makes it readable by
the electronics. A picture of the electronics setup is seen in Figure 3.5.
Figure 3.5: The electronics of the detector are shown with the necessary high voltage, a
preamplifier, and amplifier, the ADC, and finally the computer which uses the Maestro
software to analyze the γ-spectra.
In order for the samples to be placed in a position that could be measured with respect to
the position of the detector, a centering device was developed for the detector chamber as
seen in Figure 3.6. The development and use of the centering device is discussed further in
section 3.2.2.
3.2.2 γ-Ray Measurement Test Bench
The 80.6 keV γ-ray emitted by 166Ho can be used to make a measurement of the activity
of a test sample and later on the activity of the 166Ho patch. The activity must be carefully
controlled in order to provide the best therapy to the patient, thus the accurate measurement
of the activity produced by the radionuclide is necessary before radiotherapy is possible. To
measure the activity, a low-energy HPGe detector is used as discussed in section 3.2. Due to
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Figure 3.6: Schematic of detector and centering device set-up.
the need for absolute activity measurements, an accurate and precise detector set-up must
be in place and the detector must be well characterized (referring to efficiencies and detector
geometry). A centering device, which can be removed and replaced with precision, was built
to center the irradiated samples. The design of the centering device base and top plate can
be seen in Appendix A. Figure 3.7a and Figure 3.7b show the device that is placed into the
detector chamber. The base (seen by itself in Figure 3.8b) is put into the detector chamber
first in any of the corners. The right back corner was chosen so that adjustments could be
made easily. The end cap of the HPGe detector has its center marked. The laser, which can
be seen in the picture on the left, sits in a notch which is centered on the plate. The ladder
is then centered by lining the laser up with the cap. To keep the device centered, the base
seen in the picture on the right is used. The plate has adjustable screws so that the scissor
jack stays in the same place once it has been centered. As can be seen in Appendix A, four
screws keep the ladder in place.
The scissor jack allows for vertical adjustment. Height adjustment is necessary for samples
differing in activities. Higher activities need to be farther away so the dead time is low enough
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(a) (b)
Figure 3.7: Centering device components: top plate (a) and lab jack (b).
for the electronic equipment to get accurate readings. The lower activities must be closer to
the detector, so the count rate is high enough to provide distinct peaks in the γ-spectra. If
adjusted, the height must be measured each time and the scissor jack recentered. A picture
of the centering device in the detector chamber is seen in Figure 3.8a. The centering device
in relation to the HPGe detector can be seen in the schematic in Figure 3.6. The distance
from the ground to the end of the detector cap was measured with a tape measure and had
an error of ± 0.5 cm. The height of the lab jack was measured with the same tape measure
with an accuracy of ± 0.5 cm. To find the combined error in the height used for the solid
angle measurement, equation 3.3 is used.






L is the distance from the source to the detector, L0 is the distance from the detector cap
to the chamber floor, L1 is the height of the lab jack, and ∆L0 and ∆L1 are the associated
errors. Equation 3.3 gives an overall error in the distance from the lab jack to the end of the
detector cap to be ± 0.71 cm.
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(a) (b)
Figure 3.8: The centering device is shown in the detector chamber (a); the base is shown
by itself (b).
3.3 Characterization of Experimental Setup
The energy calibration, geometric efficiency, and background readings must be known in
order to carry out measurements on the 166Ho samples effectively. The energy calibration
allows the energy of the γ-rays and x-rays to be identified. The geometric efficiency allows
the activity to be calculated from a sample based on the detection efficiency of the detector
and the position of the radioactive sample. Both the energy calibration and the geometric ef-
ficiency measurements require well-known sources. The geometric efficiency characterization
also requires that the sources be calibrated.
3.3.1 Energy Calibration
The energy calibration is done using the MAESTRO program and calibrated sources.
The sources used for the energy calibration were 133Ba and 152Eu. The sources are placed
under the detector until well-defined peaks appear from the sources. The peaks used for
the energy calibration can be see in Table 3.3. Since the 133Ba source has five visible peaks
that will appear in the γ-spectrum from the low-energy HPGe, the five peaks seen in the
spectrum correlate to the known decay energies of the 133Ba source. The spectra from the
sources can be seen with their peaks identified in Figure 3.9 and Figure 3.10. The energy at
which the 166Ho γ line will appear is denoted in Figure 3.10.
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Figure 3.9: The γ-spectrum of the 133Ba source is shown with the relevant peaks marked.
Figure 3.10: The γ-spectrum of the 152Eu source is shown with the relevant peaks marked
as well as the energy of the 166Ho energy marked with a line.
Each peak is selected and an energy value given from the known decay energies using
the calibration tool in MAESTRO. The more peaks that are used for the energy calibration,
the more accurate the energy calibration will be. MAESTRO does use a slightly quadratic
solution for the energy calibration, but it is largely linear. In the setup configuration used
in these experiments, the resulting energy calibration using both sources can be seen in
equation 3.5.
E(bin) = −3.27 + (8.68 · 10−2)bin− (4.10 · 10−7)bin2 (3.5)
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3.3.2 Efficiency
Once the centering device was set up, the efficiency for a specific geometry was calculated
for the detector using sources of 133Ba and 152Eu whose activities are known to ±5 %. γ-
spectra for these sources are well-known and can be used to find accurate efficiencies as well
as an energy calibration. The calibrated sources were placed 31.8 ± 0.7 cm (the highest
point the ladder reaches) from the end of the detector, because the sources are of activity
on the order of 0.1 µCi. By keeping the calibration sources in the same position in the
detector chamber, the solid angle did not change and this reduces error in the efficiency
measurements for the detector as long as the ladder and the source stay in the same place.
The efficiency calculated only applies for the geometry setup of the source being centered
with respect to the detector at a distance of 31.8 cm from the end. For any change in the
ladder height, a new geometric efficiency must be found. The calibrated sources were placed
in the detector chamber and several measurements of six hours each were taken. The longer
running time gives well-defined peaks in the γ-spectrum and low error in the collected counts
by reducing the FWHM. The efficiencies were calculated and can be seen in the graph below.







where Nγ,det is the counts detected by the HPGe of the specific γ-ray being observed and






I is the intensity of the decay, ∆Ω is the solid angle of the detector with respect to the
source, ∆t is the amount of time that measurements were collected, A is the activity of the
source. Using this relation and points collected from the 133Ba source and the 152Eu source,
the efficiencies were determined. The error is determined by using the equation in 3.8 which
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Data was collected for 6 h on the HPGe. Using equations 3.6 and 3.8 for the calibrated
sources the geometric efficiency was found for each known peak and intensity of 133Ba and
152Eu. A quadratic was fitted to the data points using Mathematica. The efficiency fit is
Table 3.3: Geometric efficiency values found from calibration sources
Source Activity (Bq) Energy (keV) εgeom(%)
133Ba 3737 ± 187 81.0 0.123 ± 0.009
276.4 0.042 ± 0.006
302.9 0.029 ± 0.003
356.0 0.023 ± 0.002
383.8 0.018 ± 0.003
152Eu 4884 ± 244 121.8 0.100 ± 0.008
244.7 0.038 ± 0.005
344.3 0.025 ± 0.002
411.1 0.017 ± 0.008
444.1 0.017 ± 0.004
seen in equation 3.9.
ε(E) = 8.89 · 10−7E2 − 7.46 · 10−4E + 0.175 (3.9)
E is the energy in keV at which the efficiency of the detector applies and the resulting
efficiency is in percent. The geometric efficiency plot with the fitted quadratic is seen in
Figure 3.11. The geometric efficiency fit does not keep increasing indefinitely as the energy
decreases. At some low energy, the maximum geometric efficiency will be reached and the
detector efficiency will decrease very rapidly. The calibration sources did not have low enough
energy peaks to see the drop in geometric efficiency so it is unknown where it begins. This is
why the activity of the 166Ho samples will only be deduced from the 80.6 keV line, which is
very close to the 133Ba 81 keV measurement point. The 166Ho x-rays are of too low energy to
know the corresponding efficiency, which means the activity cannot be accurately calculated
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from those peaks.
Figure 3.11: The efficiency of the HPGe detector being used to count 80.6 keV γ-rays at a
distance of 31.8 ± 0.7 cm.
The validity of the efficiency diagram is checked using the calibrated sources. The sources
were put under the detector again and checked to see if plugging the counts collected and the
efficiency fit in equation 3.9 and then into equation 3.7 what the activity yielded would be.
The data for the 133Ba source is shown in Table 3.4. The values measured from the calibrated
source using the efficiency fit are all within the calculated error. This proves that the results
are reproducible and no obvious errors were incorporated into the efficiency correlation.
3.3.3 HPGe Background Measurements
An important aspect of γ-ray measurement is having a γ-ray background well-understood.
Knowing what peaks to expect from the background helps rule out peaks as contaminants
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Table 3.4: Efficiency values found from calibration sources
Energy (keV) Intensity Calculated Activity (µCi)
Calibrated Source Activity: 0.101 ± 0.005 µCi
81.0 0.3411 0.102 ± .008
276.4 0.0715 0.115 ± .019
302.9 0.1830 0.095 ± .008
356.1 0.6194 0.103 ± .008
384.0 0.0591 0.138 ± .022
as well as alerts to the presence of contaminants. To get a background, the HPGe detector is
allowed to collect measurements without any sources in the detector chamber for an extended
period of time, in this case 6 h. The resulting background is shown in Figure 3.12.
Table 3.5 has been compared with other backgrounds most notably in [25]. The peaks listed
in Table 3.5 are the ones marked in Figure 3.12; however, for a complete list of background
peaks seen in HPGe detectors, look at [25]. For the HPGe used in these experiments, this is
the characteristic background. These peaks are there regardless and should not be mistaken
for contamination. If these peaks become quite large during a run with a source this may
be due to contamination, but if they stay on the same relative order of size, then they are
background radiation.
3.4 Measurement of 166Ho Sample
It is now possible to make measurements of the activity of a 166Ho sample. For this
first sample, the holmium oxide is sealed in plastic. Due to the anticipated irradiation time
being a minute, the plastic will survive the heat of the region surrounding the reactor core.
The plastic is mostly made of light materials (carbon, hydrogen, oxygen, etc.), but in the
event that there are other elements able to be irradiated, these will appear as peaks in the
γ-spectrum. Before we irradiate a sample of 165Ho, an estimated value of the activity must
be made. To do this, we need to know the rate of activation first shown by equation 3.10.
R = NtargetsφfluxσHo (3.10)
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Figure 3.12: A background spectrum is shown with the related lines shown, their energies
and contributing species are in Table 3.5.
R is the rate of activation in s−1, Ntargets is the number of targets (or
165Ho atoms) in the
sample, φflux is the neutron flux in the reactor where the sample is, and σHo is the neutron
capture cross-section of 165Ho (which according to [14] is 60 b). The neutron flux for this
experiment was actually 1.17 · 1012 n
s ·cm2 in the dry tube at the USGS TRIGA reactor when
this experiment was done according to the NVT for the sample. This is lower than what is
discussed in section 3.1, because the neutron flux measurements made were done after a fuel
shuffling in the core, whereas this sample was irradiated prior to the fuel shuffling. Ntargets is
found by using the measured mass and the known atomic mass of 165Ho as seen in equation
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Table 3.5: The peaks are identified from the HPGe detector background. Question marks
indicate a peak that the cause is unknown by which it is produced. Some peaks were lower
than were corroborated by other backgrounds.
Energy (keV) Peak Energy (keV) Peak
17.69 Too low 199.02 228Ac
21.74 Too low 203.57 235U
52.39 214Pb 212.77 227Th
62.43 234Th 238.57 212Pb
65.66 73mGe 253.45 208Tl
68.32 73∗Ge 278.57 228Ac
86.74 PbKb2 325.72 228Ac
92.17 234Th 343.37 227Th
96.86 ? 351.21 214Pb
109.74 235U 382.93 ?
139.87 75mGe 461.06 214Pb
159.55 77mGe 511.82 electron annihilation
162.63 235U 587.89 208Tl







The mass of 165Ho is denoted by mHo, NA is Avogadro’s number, and MHo is the atomic
mass of 165Ho. Since we are using holmium oxide (Ho2O3), we need to determine the mass
of holmium oxide needed to get the desired mass of 165Ho for irradiation. This is done with





MHo and MO are the molar masses of oxygen and
165Ho. Finally, we can use the rate of
activation and the exponential decay to determine the activity of the sample of a certain
mass and certain irradiation and cooling times by using equation 3.13.
Apredicted = R(1 − e−λtirradiated)(e−λtcooling) (3.13)
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Using this equation and a 5 mg Ho2O3 sample that was irradiated for 1 minute with no cool
down time, the predicted activity is 13.0 µCi. The error in this predicted activity is unclear,
because the neutron flux in the reactor is not well-known at this point (it was done before
neutron flux experiment was done). It is now possible to irradiate a sample of Ho2O3.
The 5 mg sample was irradiated in the USGS TRIGA reactor for one minute with no cool
down time. The sample was irradiated before the centering device was complete, meaning
the activity measurement is not as accurate as it will be in future measurements. The 166Ho
measurements were taken for one hour at a time for a total of 244 separate measurements.
The dominant γ-ray peak seen in the detector is the 80.6 keV γ-ray as seen in Figure 3.13.
The holmium activity as a function of time is shown in Figure 3.15. Due to this plot
showing the γ-spectrum within the first hour after irradiation, it is not possible to see minor
contaminants or background radiation in comparison to the 166Ho peak.
In order to determine whether there are also contaminants present, Figure 3.14 shows the
holmium activity after the initial sample was allowed to decay significantly.
The κα2 x-ray (47.9 keV) and the κβ1 x-ray (54.5 keV) are easily seen in the spectrum in
Figure 3.14. Interestingly, although the x-rays should have a greater activity than the 80.6
keV γ-ray, the peaks are considerably less. This is most likely due to the efficiency of the
detector decreasing steeply in this particular area of the energy spectrum. Other peaks seen
are the 234Th peak at energy 92 keV, the 75mGe peak at 140 keV, the 235U peak at 162 keV.
The 183 keV peak is also a 235U peak that was found in Bossew [25], but is so small, it is
difficult to see in longer counts like the background count taken section 3.3.3.
An exponential curve was fitted to the data using Mathematica in order to find the decay
constant. The exponential fit is in equation 3.14. T1/2 is the half-life in hours, and N0 is the
initial number of counts.






Figure 3.13: The γ-spectrum of a 1 hour measurement of 166Ho with the 80.5775 keV peak
denoted.
This gives a half-life of 26.822(34) h. The accepted half-life of 166Ho is 26.824(12) h. The
measured half-life shows consistency and no deviation, meaning that the sample radioisotopes
are comprised of only 166Ho in any measurable quantity. To deduce the activity of the sample,
the counts of 80.6 keV γ-rays were collected using the HPGe detector. The 80.6 keV γ-ray
only accounts for 6.565 % of the entire activity, which also includes β and x-ray radiation.
This means that the total activity will be much greater than the activity due to the γ-
ray only. Using the first γ-ray measurement from the 166Ho sample, the total activity was






Figure 3.14: The γ-spectrum of the 166Ho sample after it has decayed for 242 hours. X-rays
from internal conversion are easily seen.
ε(E) is the geometry efficiency related to the energy found previously. The measured activity
due to all radiation is 15.69 ± 0.78µCi. The predicted value is 13.0µCi. The difference in
activity is probably mostly due to the uncertainty in the neutron flux at the irradiation site.
A measurement in mR
hr
is used as an additional check as the USGS measures the activity
of the sample in terms of its radiation field. They measured a radiation field of 10.8 mR
hr
.
To determine the radiation field from the absolute activity measurement, the intensities and
energies of the x-rays emitted by the 166Ho needed to be determined, because these contribute
to the overall ionization activity measurement made by the USGS facility. Equation 3.16






E is the energy of the γ-ray or x-ray in keV. A is the activity of the particular γ-ray or x-ray
in µCi. The x-rays and their associated energies and intensities were found in ENSDF files
[14]. The x-ray activities, determined from the initial γ-ray activity measurement and their
33
Figure 3.15: Evaluation of the 166Ho 80.6 γ-gated activity of a 5 mg sample irradiated for 1
minute with superimposed exponential fits as functions of time.
associated ionization activities are in Table 3.6. The intensities in Table 3.6 are relative to
every 100 emissions of 1379 keV γ-rays
The total radiation field measured was 2.2 mR
hr
, as compared to the measurement from the
USGS which was 10.8 mR
hr
. There is significant deviation from the USGS value. Obtaining
agreement between the actual measurement and the calculated radiation field is quite diffi-
cult. There could be a number of external factors that contribute to the difference seen in
the two measurements. Although the measurements do not match, the activity measurement
is more important due to the ability to determine the activity much more precisely. It may
be necessary to employ a different measurement device. Photographic film may be used to
show the effect of the radiation on a material. It can show better how the radiation interacts
at different depths, as well as indicate secondary damage caused by the interaction of the
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Table 3.6: Activities of γ-rays and x-rays corresponded to mR
hr
.
Radiation Energy (keV) Intensity Activity (µCi) mR
hr
γ-ray 80.6 712 1.029 0.50
γ-ray 1379.4 100 0.145 1.19
κα2 48.2 346.11 0.500 0.14
κα1 49.1 613.22 0.886 0.26
κβ1 55.7 194.8 0.282 0.09
κβ2 57.1 47.2 0.068 0.02
Total 2.8
radiation with other electrons and particles present in the body. However, it is fairly accu-
rate given the conditions, so an accurate prediction of the activity of the irradiated samples
is possible as long as the mass of the sample is known.
Finally, the dose due to the activity from the sample was determined. The dose to a
patient using the 166Ho sample was found using the activity right after it was removed from
the detector and using the radioisotope for 30 minutes for a similar sized skin malignancy




DEVELOPMENT OF THE SKIN PATCH
In order to make the patch, a few calculations were done to show what might be needed
for the 166Ho skin patch being developed in this research to get similar results as the work
done in [1]. An example of what parameters would be needed for the development of the
holmium skin patch are shown in the following calculations. A 60 minute irradiation time
was chosen, because the USGS TRIGA reactor facility can easily irradiate a sample for an
hour, but this also means that the thickness of the deposition does not have to be as thick
as one would see if the irradiation time was planned to be only 1 minute. According to
Treatment of Bowen’s disease with a specially designed radioactive skin patch [19], the dose
administered to a patient which successfully eliminated the Bowen’s disease (a type of skin
cancer) was 35 to 50 Gy. The β-particles will provide the major component of therapy to the
affected area so the energy they carry will be used for the calculations. Using this dosage,
it is possible to predict the needed activity from the 166Ho sample as well as the mass and
thickness of Ho2O3 needed on the Kapton tape. The calculation for activity, mass, and
thickness follows. The highest β-particle energy was about 1.8 MeV. The average β-particle
energy is about 0.9 MeV. The equivalent energy in J
decay





= 1.6 · 10−13 J
decay
(4.1)
0.9 MeV is thus equivalent to 1.44 · 10−13 J
decay
. An average size of the Bowen’s disease skin
malignancies which trials were performed was 1 cm2 with a depth of 3 mm (although there
can be much variation in size) [19]. The density of adipose tissue is 0.95 g
cm3
. The mass of
skin that a dose is desired to penetrate is found by using the volume of skin and the density
of adipose tissue as seen in equation 4.2.
mskin = Vskin ρskin (4.2)
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The mass of skin being treated is then approximately 0.28 g. The energy absorbed in the
patient trials is found by taking the dose measurement and multiplying it by the mass of
skin as seen in equation 4.3.
Eabs = mskinDose (4.3)
The total energy absorbed in the patient trials was 0.00998 or approximately 0.01 J for a 35
Gy dose. The number of decays needed to supply a dose of 35 Gy to the patient is found by
dividing the needed absorbed energy by the energy of the β-particle and then multiplied by
two to account for roughly half the decays being emitted away from the cancerous region as





This gives a total number of decays needed as 13.9 · 1010 decays. According to [19], the
duration of holmium patch therapy was 30 minutes. Dividing the number of decays by the





The activity of the patch must be at least 7.70 · 107 Bq or 2.08 mCi then. This is an
approximate value of the needed activity for the holmium skin-patch to be effective. As
will be discussed in section 4.1, a holmium oxide (Ho2O3) sputtering target will be used to
deposit Ho2O3 on to Kapton tape. To find the mass of holmium needed for the irradiation,
the equations 3.10, 3.11, 3.12, and 3.13 are used. Equation 3.13 is used to find the desired
reaction rate. Equation 3.10 is used to find the number of holmium atoms needed. The mass
of 165Ho can be calculated using mHo =
NHoatomsMHo
NA
. The mass of holmium oxide can then
be found using equation 3.12. The needed total mass of 165Ho to produce an activity of 2.08
mCi is then 13.8 mg (which is 15.8 mg of Ho2O3). Approximating that most skin patches
will have an area of 1 cm2 and since holmium has a density of 8.79 g
cm2
, the thickness (d) of
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The skin patch will need a deposition of about 1.87 µm of Ho2O3.
In order to prove that very little dose will come from 166Hom, the activity due to 166Hom
was calculated. The neutron capture cross-section of 165Ho is 3.5 b; the half-life of 166Hom is
1200 y. Using the same mass of 165Ho to produce 35 Gy of 166Ho in the ground state, which
was 13.8 mg, the relation in equation 3.13 for the activation rate of a material is used to find
that 11.8 mg of 165Ho irradiated for 60 minutes produces 0.31 nCi of activity. The activity
(and consequently the dosage) due to 166Hom is negligible.
4.1 Sputtering Data
Due to the high melting temperature of holmium oxide (2415 ◦C), the Ho2O3 was de-
posited on the Kapton foil by RF sputtering. A Ho2O3 sputtering target was acquired from
Kurt J. Lesker. Sputtering works by applying a bias to the target (in this case holmium
oxide). A plasma is created from a gas using radio frequency (RF). In order to get the
plasma started, the pressure of the sputtering chamber must be slightly higher. By letting
the sputtering chamber come to 25 mTorr, the plasma is able to start. Once the plasma
has started, the chamber pressure can be brought down to 5 mTorr and maintained at this
pressure. The pressure needs to stay steady otherwise the deposition rate will vary with the
changing pressure. The ions then hit the target and break the bonds holding the holmium
oxide molecules to the target. Gas molecules are then used to carry the holmium oxide
molecules up to the substrate. The holmium oxide molecules stick to the substrate material,
because they are no longer subjected to the plasma ions. Argon is the typical gas used for
sputtering, because it is not reactive. Argon was used as well as oxygen to ensure that the
holmium oxide did not become oxygen deficient (although in regards to discovering the mass
of holmium deposited it did not affect the outcome much if the sample was slightly oxygen
deficient). Samples were sputtered using 90 % argon and 10 % oxygen. A higher deposition
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rate is desired in order to make depositions quickly. To do this, the RF power supply should
be set to 150 W. 150 W is the highest power that this sputtering chamber can maintain for
long periods of time. The power should be increased from lower powers to the 150 W in
order for adjustments to be made to the reference power. The reference power shows if the
plasma is arcing, which is undesirable as this can cause damage to the equipment. If the
reference power is at 0 W, the plasma is not arcing. If the reference power starts to increase,
this can mean that the plasma has started to arc. Tune and load knobs are used to adjust
bring the reference power to 0 if a rise in the reference power is seen. When the RF supply is
at 150 W, the shutter is opened that keeps the target from sputtering the substrate until the
desired power is reached. The substrates were the Kapton foil and masks made from steel
with varying geometries were used to cover the Kapton in order to get the desired deposition
shapes. A picture of the masks can be seen in Figure 4.1.
Figure 4.1: The masks for the Kapton foils are shown. The circular geometry is on top and
the half-square half-circle geometry is shown below.
Glass substrates were also sputtered with the Kapton samples to measure thicknesses using a
profilometer and ellipsometer after the sputtering. The argon and oxygen gas supplies must
be opened before beginning the sputtering. A series of valves from the gas canisters must
be opened; a separate dial on the sputtering chamber set up allows for the amounts of each
gas supplied to the chamber to be controlled. The vertical arm is marked with millimeters
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from 0 to 50. The 50 mm tick mark indicates the arm and the substrate being at its lowest
point, or closest to the target. A schematic of the sputtering chamber set up is in Figure 4.2
as well as pictures of the actual sputtering chamber shown in Figure 4.3 and Figure 4.4. A
picture of the substrate holder is shown in Figure 4.5.
Figure 4.2: The RF sputtering set up is shown.
The substrate preparation procedure and sputtering procedure can be found in Appendix
B.
Sputtering samples were made three separate times. The first two times, two Kapton foil
samples were made; the last sputtering, only one Kapton foil was sputtered. The goal was
to sputter between 0.25 and 0.5 µm of Ho2O3 onto the Kapton foil. Data was collected from
each sputtering.
Thickness measurements are made using the glass samples, since the Kapton will not neces-
sarily lie flat resulting in inaccurate thickness measurements. The deposition was extremely
thin. Highly nonuniform measurements were discovered using a profilometer. It was thought
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Figure 4.3: The RF sputtering chamber is shown with the sputtering chamber visible.
Figure 4.4: The RF sputtering chamber is shown so that the vertical and horizontal arms
are seen.
that due to the thinness of the deposition that the profilometer was unable to read the thick-
ness, because it appeared nonuniform. However, when attempting to use an ellipsometer for
thickness measurements, it could come up with no value due to the deposition being ex-
tremely nonuniform. The profilometer was accurate enough to pick up the major differences
in thickness of the deposition. Due to the sputtering rate being extremely low, the next
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Figure 4.5: The substrate holder is shown with the bottom facing up. The figure shows the
metal arms and screws in which to hold the substrates.
sample was attempted at a reference power of 200 W. However, the RF supply could not
handle that power for very long, and the power was brought back down to 150 W.
The measurement made for this sample were also highly nonuniform. The ellipsometer could
not measure the deposition. Values were found using the profilometer and measuring the
film in different places.
4.2 Irradiation of Holmium Patch and Resulting Activity Results
Despite the thinness of the patch, a test irradiation was done to determine the activity
of the patch as well as the mechanical stability of the patch after irradiation. A sputtered
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Table 4.1: Data from the first sputtering trial is listed. Two Kapton samples were
sputtered. The mask geometries used were the circle and the half circle - half square. One










— 25 50 52 0 closed
1 min. 5 50 52 0 closed
1 min. 5 70 82 0 closed
1 min. 5 90 110 0 closed
1 min. 5 110 147 0 closed
1 min. 5 130 165 0 closed
1 min. 5 150 248 0 closed
1 hr. 5 150 248 0 open
Thickness of Ho2O3: unmeasurable
holmium skin patch was irradiated for 16 minutes in order to see the resulting activity of the
radiotherapy patch. The determination of the activity based on the irradiation time can also
help to compare if the thickness measurements were truly indicative of the deposition. The
sample from Table 4.3 was used for this irradiation. Instead of allowing it to be folded in
the cylindrical tube used for the irradiations, the holmium patch was cut down to fit inside
the container. This was done with scissors and gloves; the scissors were cleaned with alcohol
before being used to avoid contamination of the patch. When the holmium patch was the
right size, the sample was put into the tube and irradiated in the lazy susan for 16 minutes.
The sample was then allowed to cool for 1 h 50 m, not for any specific reason, but this is
when the USGS faculty was able to deliver the sample. The sample was left inside the tube
and put under the HPGe detector. The detector collected data for 26 h. The γ-spectrum
can be seen for the first hour of collection and the 26th hour of collection in Figure 4.6,
Figure 4.7, and Figure 4.8.
The 417.6 keV peak is an unknown peak which may be due to the irradiation of the Sharpie
pen markings on the irradiation tube or it could be part of the natural background. According
to [25], a 416 keV peak appeared appeared in their background as well. Due to its fairly
quick disappearance in the later spectra, it is most likely from the irradiated ink on the tube.
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Table 4.2: Data from the second sputtering trial is listed. Two Kapton samples were
sputtered. The mask geometries used were the circle and the half circle - half square. One










1 min. 27.5 50 27 0 closed
1 min. 5 70 57 0 closed
1 min. 5 90 86 0 closed
1 min. 5 110 114 0 closed
1 min. 5 130 138 0 closed
1 min. 5 150 160 0 closed
1 min. 5 175 188 0 closed
1 min. 5 200 212 0 closed
10 min. 5 200 290 0 open
Plasma arced and died after 10 minutes
1 min. 25.6 150 168 0 closed
2 hr. 20 min. 5 150 229 0 open
Thickness of Ho2O3: 50 - 100 nm
Table 4.3: Data from the third sputtering trial is listed. One Kapton sample was sputtered.
The mask geometry used was the square. One glass sample was also sputtered with the










— 25 50 43 0 closed
1 min. 5 70 51 0 closed
1 min. 5 90 105 0 closed
1 min. 5 110 162 0 closed
1 min. 5 130 201 0 closed
1 min. 5 150 226 0 closed
1 hr. 5 150 242 0 open
Thickness of Ho2O3: unmeasurable
Irradiating the tube without a holmium sample inside and measuring the γ-spectra is the
next step to making sure that this peak is due only to the container or natural background
and not contamination of the holmium radiotherapy patch.
The presence of the 64.8 keV peak is a background peak which can be seen in the
background measurements in section 3.3.3. The peaks are decaying away as expected.
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Figure 4.6: The γ spectrum is seen with the 80.6 keV γ peak and the 49.1 keV and 55.6
keV x-rays after an hour of collection in the low-energy range of the spectrum.
Figure 4.7: The γ spectrum is seen with a 417.6 keV γ peak and a 511.8 keV peak after an
hour of collection in the high-energy range of the spectrum.
Data was collected by the detector in 1 h increments. The peak the 80.6 keV γ-ray were
measured. Using the same technique as in section 3.4, the data was plotted in a log plot for
the γ-ray. Using Mathematica, an exponential was fit to each set of data. The data and the
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Figure 4.8: The γ spectrum is seen with the 80.6 keV γ peak and the 49.1 keV and 55.6
keV x-rays after 26 h of decay in the low-energy range of the spectrum.
fitted exponential can be seen in Figure 4.9. This allowed the half-life to be found from the
decay constant. The activity of the sample was found using the same methods as in section
3.4, keeping in mind that the sources had 1 h 50 minutes to decay.
The half-life from the 80.6 keV γ-ray was measured to be 26.902(5) h showing no signif-
icant deviation from the accepted value of 26.824 h. The half-life shows, again, that 166Ho
has been produced and it is the only radionuclide that has been produced in any significant
quantity. The total activity of the holmium patch was found to be 7.03 ±0.35µCi, which is
the best calculation of the activity, because the absolute efficiency was measured very near
the 80.6 keV energy. Looking backwards, in order to produce this activity in 16 minutes, a
total mass of 0.072 mg of holmium oxide is needed to reach that activity. An activity was
predicted knowing that the thickness of the deposition is 75 nm ± 25 nm. Using a neutron
flux of 3.3 1012 ± 109, the predicted activity of the sample is 7.39 µCi (+20.71, -7.39) µCi.
The averaging of the thickness appears to have been a decent approximation, because the
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Figure 4.9: The decay of the holmium sample can be seen by the lessening of counts
detected from the 80.6 keV γ-ray emission.
activity predicted it surprisingly close to the measured activity. However, there is a huge
error due to the propagation of the error in the thickness measurement.
In order to determine if the sample had delaminated, after the first 26 h of decay the
holmium patch was carefully removed from the container. The plastic tube was then placed
under the detector to see if the holmium peak showed up. If a holmium peak was present, it
would indicate that holmium delaminated and fell off the Kapton foil. The γ-spectrum can
be seen of the container that held the 166Ho patch before it was removed in Figure 4.10.
The peaks can all be found in the background spectra in section 3.3.3 with the exception of
the 63.3 keV peak. The peak measured was quite broad and most likely it was the combined
peaks of the 62.4 keV peak and the 65.7 keV peak combined. The container showed no decay
peaks from the 166Ho sample, so there was no delaminated holmium in the container. This
means that the patch will stay relatively intact as long as it is not bent too much. How
much is too much is not known at this point.
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Figure 4.10: The spectrum of the container that held the 166Ho therapy patch during and
after irradiation is shown with the 166Ho patch removed.
Although the predicted activity of the prototype holmium radiotherapy patch was quite
close to the measured activity, the error in this prediction was quite large. The error was
due to the unknown deposition thickness, which was caused the RF sputtering method.
The most apparent issue with the RF sputtering was the extremely thin depositions that
resulted even after very long sputtering times. Due to low power, the large mass of the
holmium oxide compound compared with the mass of the sputtering gas, and the difficulty
of energizing oxides, the deposition rate of the holmium oxide onto the Kapton at a power of
150 W was somewhere between 0.006 and 0.011 Å
s
. It is possible to increase the deposition
rate by increasing the power, however, the sputtering device was not able to exceed 150 W
without arcing. Added to this, the depositions were highly nonuniform. The thin uniform
was very difficult to measure and appeared nonuniform. Nonuniformity makes it impossible
to get an accurate thickness reading using a profilometer or an ellipsometer, which means
that the mass is not able to be calculated accurately. With an unknown mass of holmium
oxide deposited on the Kapton, the predicted activity measurement has a very large error.
It is possible that for future therapy, the patch could be irradiated to be at an estimated
higher activity than needed. The activity would then be measured using γ-spectrometry
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and allowed to cool to the desired activity before the radiotherapy is administered. Another
solution to the poor sputtering depositions is using a metal holmium target as compared
to the holmium oxide target or a high power sputterer. Most holmium sputtering has been
done using reactive sputtering. This involves a metal holmium target that is sputtered
using oxygen gas. The holmium and oxygen combine and the thin film that results is then
holmium oxide as compared to the holmium metal that it began as. A metal holmium target
in theory would be easier to excite and the literature shows a rate of 0.6 Å
s
at 100 W [26],
which is significantly higher than the current deposition rate. Holmium metal will have a
faster deposition rate than holmium oxide due to the fact that metal holmium is easier to
excite than holmium oxide. The other reason for the slow deposition rates, is that the argon
and oxygen are much lighter than the holmium oxide. The lightness of the sputtering gas
makes it difficult to excite the holmium metal or holmium oxide. There is also more data on
metal holmium sputtering than there is on holmium oxide sputtering. There is no reason for
the oxygen to be present for the radiotherapy. However, metal holmium targets are slightly
more expensive. For future work, a silicon sample (not glass) should be included with the
substrates for sputtering, glass can be quite nonuniform. This way ellipsometry is possible if
the deposition is uniform which means that the film does not have to be as thick for accurate
thickness measurements.
4.3 Measurement of β-Particle Interaction Using Photographic Paper Exposure
For the characterization of how the β-particles will affect human skin, photographic paper
is employed. Photographic paper can show how far the β-particle can penetrate (high linear
transfer) and how well contained (spatial diffusion) the radiation is. This is done by placing
the irradiated holmium patch onto a stack of photographic paper for a certain amount of
time. The β-particles (and to a lesser extent the γ-rays) will interact with the photographic
paper and show how the radiation behaves. In order to see how the β-particles might
penetrate the skin, a stack of photographic paper were used to show the change in radiation
interactions as the thickness increased. The photographic paper used was measured with a
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micrometer and is approximately 0.18 mm thick. The exposures were done on 9 pieces of
stacked photographic paper to give a total thickness of 1.62 mm. The photographic paper
should then show to some degree the penetration of the β-particles. The process for the
photographic paper exposures is seen in Appendix C.
4.3.1 Photographic Exposures of Four Holmium Patches
Four holmium patches were irradiated initially for the exposure tests. The samples from
Table 4.1 and Table 4.2 were used for the irradiation. Due to the unknown masses of holmium
oxide on the Kapton foil, an estimate was reached for each sample. To obtain an activity of
10 µCi from a sample from Table 4.2 and if the average thickness is 65 nm, then the samples
must be irradiated for 16 minutes in the lazy Susan. The other samples were irradiated
for the same amount of time, so the expected activity if the average thickness is 35 nm is
approximately 5 µCi. This gives a total activity of the four patches to be about 30 µCi.
Unfortunately, these predictions are extremely inaccurate due to the nonuniform thickness
of the sputtering. Once the patches were irradiated, the USGS did a measurement of the
radiation field. The radiation field was measured to be 24 mR
hr
. 9 sheets of photographic paper
were placed on the holmium patches for 45 minutes. According to [1], radiation therapy was
administered for 30 minutes to 1 hour. 45 minutes will show how the radiation works over
an extended time period, although the dose is much less than it would be for actual therapy.
The photographic paper was then developed. In Figure 4.11, the exposure shows where the
photographic paper received a dose from the radioactive patch. The dark patches represent
where the photographic paper was irradiated by the β-particles. The patches seen in the
upper left and right of the photographic paper show the samples from Table 4.2. The
darkened areas in the lower left and right of the photographic paper show the samples from
Table 4.1. Significant contamination can be seen in the lower left and right exposures.
It was discovered soon after the exposures began that the irradiated holmium had not been
contained. This was discovered by a portable Geiger counter alarming. It is thought that
because the holmium patches were placed in a cylindrical tube and bent that the holmium
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Figure 4.11: The photographic paper that was placed nearest to the irradiated holmium
patches. Contamination can be seen quite dramatically in the lower samples, and to a
lesser extent in the top samples.
oxide delaminated. The contamination is quite apparent on the first few exposures on the
bottom samples. Significantly less contamination is seen on the top samples. Interestingly,
the samples on the bottom were the first samples to be sputtered. It may be that the
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contamination was not holmium oxide and the Kapton picked up other particles in the
sputtering chamber which were not present in the next samples because they had been
cleared away by the first sputtering. It is also possible that the thinner layer of holmium
oxide was more susceptible to delamination than the thicker holmium oxide depositions. At
this point, it is clear that if the patches remain with sub-micrometer depositions the holmium
oxide will need to be contained using some sealing method. Suggestions as to placing Kapton
tape or other thin plastic cover over the Kapton foil once the sputtering process is done may
be a viable options. The other photographic paper exposures can be seen in Appendix D.
The contamination that can be seen clearly on the first few photographic papers is very
difficult to see around Figure D.8 and Figure D.9. This may be due to the γ-ray effects. The
γ-rays may also be causing the blurring around the edges of the deposition. The γ-rays do not
necessarily possess the same high-linear transfer that the β-particles do. The interaction of
γ-rays with the photographic paper is quite possibly dropping off faster than the β-particles,
which is why the photographic papers farther from the holmium radiotherapy patch appear
to be less affected by the delamination and resemble the deposition geometry more closely.
4.3.2 Densitometer Measurements of Holmium Patch Exposures
After the photographic paper has been developed, the radiation effect on the paper can
be measured using a densitometer. The densitometer measures the amount of undeveloped
or clear paper as compared to the amount of dark paper. Experimental samples can be seen
in Appendix D. The densitometer is set up in the following manner. It is connected to wall
power. Every time the power is turned on, the machine needs to be zeroed. Zero the machine
by pressing the reader down and hitting the “zero ”button. Once it is zeroed, the reader
can be allowed up. To make sure the reading is still calibrated properly, the densitometer
comes with a piece of photographic paper that has been exposed to varying degrees and
the related densitometer readings. For every densitometer measurement, the photographic
paper is lined up with a cross hair on the machine and the reader pressed down for a few
seconds and then let go. The value is shown on the digital display on the densitometer.
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There is no need to reset after the measurements, each time the reader is pressed down, a
new measurement is made. The densitometer is accurate to ± 0.02 D. D is the measure in





Where T is the percentage of light that transmits through the item being measured, in
this case the exposed photographic paper. As the photographic paper is exposed to more
light, the optical density becomes greater. The greater optical density means less light is
transmitted through the photographic paper and the value for D is greater. The densitometer
setup is shown in Figure 4.12.
Figure 4.12: Densitometer device: view of top of densitometer
The densitometer measurements of the holmium patches are shown in Table 4.4. The
densitometer works by visually lining up a light with a point on the photographic paper
that a measurement is desired. The visual nature of this makes if difficult to get consistent
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results, but the measurements do show how the radiation affects the skin in its depth and
its spatial diffusion. The points that were used to take the measurements are indicated in
Figure 4.13.
Figure 4.13: The numbers indicated on the schematic line up with the numbers under
“Point”in Table 4.4.
Figure 4.14: Example of where densitometer measurements were made if only five points
were measured.
If the exposure has 10 points, the schematic on the left of Figure 4.13 shows where
measurements on the exposures were taken. If the exposure has seven points the schematic
in the center of Figure 4.13 shows where measurements on the exposures were taken. If the
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exposure has five points the schematic on the right of Figure 4.13 shows where measurements
on the exposures were taken. An example is shown in Figure 4.14 of where the densitometer
measurements were made. The data in Table 4.4 shows the densitometer measurements of
each holmium radiotherapy patch on each photographic paper exposure. Figure 4.15 shows
where TL, TR, LL, and LR are in relation to the photographic exposures.
Figure 4.15: The photographic paper shows where TL, TR, LL and LR are on the
photographic paper.
The units of each measurement is the relative optical density (D) which is discussed above.
The photographic paper closer to the holmium radiotherapy patch will be subjected to the
most β-particles at the highest energy resulting in a darker exposure of the photographic
paper. This is seen by the higher optical density measurement. The photographic papers
farther away from the holmium radiotherapy patches show less optical density due to the
lower exposure to the radioactive particles. This can then be related to the fall-off of the
β-particles in a medium (in this case the photographic paper).
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Table 4.4: Densitometer measurements from exposures. TL indicates top left, TR top
right, LL lower left, and LR lower right as seen in Figure 4.15. Units are in D.
Point TL TR LL LR TL TR LL LR
Exposure 1 Exposure 2
1 6.34 6.10 6.03 6.01 5.54 5.39 5.10 5.41
2 5.56 6.06 6.05 6.03 5.36 5.64 5.18 5.39
3 6.09 5.93 6.09 5.72 5.52 5.36 5.10 5.31
4 6.27 6.25 6.01 6.05 5.57 5.72 4.94 5.48
5 5.75 5.89 6.21 5.88 6.06 6.11 5.84 5.92
6 5.78 5.88 6.07 5.88 5.82 6.03 5.61 5.76
7 6.42 6.38 6.34 6.35 6.05 5.91 5.66 5.69
8 6.74 6.42 6.39 6.27
9 6.47 6.33 6.38 6.29
10 7.06 6.74 6.62 6.62
Exposure 3 Exposure 4
1 5.48 5.50 4.68 4.71 5.05 4.75 3.64 3.83
2 5.32 5.40 4.88 4.64 4.97 4.74 4.00 3.92
3 5.39 5.36 4.55 4.65 4.82 4.86 3.86 4.08
4 5.38 5.26 4.80 4.69 5.10 4.89 3.77 4.05
5 5.67 5.84 4.77 5.01 5.50 5.14 3.99 4.14
6 5.54 5.83 4.74 4.96
7 5.47 5.87 4.79 4.86
Exposure 5 Exposure 6
1 4.12 4.09 2.99 3.07 3.31 3.42 2.00 2.34
2 4.04 4.10 3.28 3.16 3.32 3.21 2.04 2.41
3 4.06 4.11 3.27 3.00 3.35 3.45 2.19 2.43
4 4.08 3.98 3.02 3.05 3.37 3.17 2.17 2.44
5 4.80 4.84 3.43 3.30 4.14 4.05 2.71 2.78
Exposure 7 Exposure 8
1 2.12 2.68 1.67 1.97 1.96 2.24 1.45 1.56
2 2.25 2.60 1.77 1.90 2.00 2.09 1.55 1.58
3 2.31 2.70 1.73 1.97 1.82 2.20 1.48 1.61
4 2.36 2.77 1.72 2.02 2.01 2.10 1.50 1.68
5 3.50 3.45 2.24 2.29 2.91 2.87 1.85 1.93
Exposure 9
1 2.02 1.87 1.39 1.39
2 2.17 1.94 1.28 1.30
3 1.97 1.96 1.42 1.35
4 1.97 1.91 1.42 1.44
5 2.40 2.35 1.54 1.60
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The densitometer readings show a change in the dose as the β-particles reach farther
into the photographic paper. The photographic paper closest to the holmium radiotherapy
patches (exposure 1) has the highest densitometer readings with respect to the photographic
papers beneath them. It is also possible to see that the higher activity holmium patches are
in the top left and top right exposures from the higher densitometer readings. This is more
apparent in the photographic papers that were farther away from the radiotherapy patch.
The densitometer readings taken in the center of the exposure holmium patch spots were
normalized and then plotted with respect to the thickness of the photographic paper. These
can be seen in Figure 4.16.
Figure 4.16: The normalized fall-off of the β-particle energy absorbed can be seen in each
layer of photographic paper.
The figures show that there is a similar slope of fall off for the lower activity samples and
then a similar slope of fall off for the higher activity samples. The higher activity samples
(the samples in the top right and top left of the photographic paper) lose energy slower than
the lower activity samples. When comparing these to the simulation of the β-particles going
through skin in the VARSKIN3 simulation [13]. Looking at Figure 2.6, the normalized dose
rate shows that at about 1.5 mm of skin, the dose is at about 20 % of its initial dose. The
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bottom left and bottom right samples show a similar drop in the normalized densitometer
readings where the densitometer reading is now at 20 % of its initial value.
For some reason the fall off is more apparent in the exposures far from the patches
with values of 2.4, 2.4, 1.5, 1.6 than the ones nearer the patch with values of 7.1, 6.7,
6.6, 6.6. Slight shadowing from the sputtering can be seen in the densitometer readings
by the measurements on the edges of the patches’ densitometer readings. The edges show
the densitometer readings in the center of the exposures. The shadowing effect becomes
even more obvious in the contour plots seen in the contour plots. Figure 4.17, shows how
the amount of radiation exposure changes moving out from the center of the radiotherapy
patch. The highest amount of exposure is in the center of where the radiotherapy patch was
and is lowest at the edges.
Figure 4.17: The contour plot of the densitometer measurements of exposure 1. The x and
y positions indicate an arbitrary position, because the actual measurements between points
were not taken. Instead they show a general positional relation between the outside
densitometer measurements and the central densitometer measurements.
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Shadowing is the effect caused by sputtering on the Kapton with a mask on top of the
Kapton. The mask (although very thin metal) is still thick enough to cause the sputtering to
be slightly less near the edges of the mask. Although contamination of the radiotherapy patch
may contribute, it is most likely that the blurred edges seen in the exposures in Appendix D
are due to the spread of β-particles from the sputtered area to beyond the intended region
of therapy. The β-particles are mostly contained by area in which the holmium oxide was
sputtered, but they travel enough to damage a small region of surrounding skin. The focus
of the β-particles becomes better as they penetrate deeper into the photographic paper. It
is possible to see the shapes of the original sputtered areas in the last few exposures. The
half-square half-circle design becomes noticeable in Figure D.7 through Figure D.9. More
measurements are needed to quantify these observations. Measurements will need to be
taken after a more uniform (and probably thicker) sputtering deposition is prepared. This
may be changed with either the sputtering method (high power sputtering as opposed to





A 166Ho skin patch is an excellent candidate for treatment of some skin diseases especially
when lesion are located in places that surgery is not an option. The radiation emitted by
166Ho makes it especially desirable for superficial cancer therapy. The physical and chemical
properties of 165Ho make it an ideal candidate for irradiation in the TRIGA reactor. The
use of γ-spectrometry allows the activity of the holmium samples to be analyzed. Once a
patch is developed, the γ-spectrometry would be used to double check that the results are
as expected and sent to the clinic to be used.
Production of 166Ho from 165Ho (n,γ) in the required quantity was proven to be quite
feasible using the 1 MW TRIGA reactor. This was proven by the test irradiation in 3.4.
Furthermore, it was possible to predict the activity of the irradiated sample using the mass
of holmium oxide and the irradiation time. The activity was predicted to be 13.0 µCi, and
the measured activity was 15.69 ± 0.78 µCi.
A well-characterized experiment procedure and setup was established for this work. An
energy calibration, efficiency calibration, and a background analysis were completed for the
HPGe detector used for all activity measurements. A centering device was designed and
machined for the repeatable placement of samples.
First test skin patch prototypes were developed using RF sputtering of Ho2O3 on Kapton.
Activity measurements of the holmium patches using γ-spectrometry can be found within
10 % error. Predicting the activity of the holmium radiotherapy patch was not precise,
however. There will be error because the neutron flux within the reactor varies, for these
experiments, the mass of the sample was difficult to determine (and it was done with little
accuracy) before the irradiation of the samples. The activity of the holmium patch which
was sputtered for 1 h and irradiated in the lazy susan for 16 minutes was determined to
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be 7.03 ±0.35µCi of activity with a measured half-life of 26.90 h. The measurements will
be more predictable when a thin film can be deposited uniformly and in greater thickness.
This is one of the main ways that the experiments will need to be improved. The current
sputtering techniques showed that RF sputtering at 150 W holmium oxide had a very low
deposition rate (0.006 - 0.011 Å
s
) resulting in depositions that were either not measurable
using a profilometer or were highly inaccurate. Improvements to the RF sputtering of Kapton
will need to be made in order to produce thicker, more uniform depositions. This could be
accomplished by using a high power sputterer or reactive sputtering with a metal holmium
target. The thin deposition also proved to susceptible to delamination.
Photographic paper exposures were done using the holmium skin patch in order to see
the effects of the radiation. Delamination was discovered once the photographic papers
were developed. It would be necessary to contain the holmium, because the holmium oxide
delaminated and caused the irradiation of area outside the desired therapy site as seen in the
photographic paper exposures. This could be done by melting a thin plastic coating over the
Kapton foil or placing Kapton tape over the Kapton foil after sputtering is done. Even if the
deposition does not delaminate with minor bending and thicker depositions, it is desirable
to avoid any chance at contamination. The prototype patches showed deep penetration of
the β-particles into the photographic paper, but there is also rapid fall off which can be seen
by the much smaller densitometer readings in the photographic paper farther away from the
holmium patch. It also showed the shadowing effects which could be due to sputtering with
the masks or that radiation does not stay contained within the sputtered area. For therapy,
it may be necessary to shrink the area that is sputtered with relation to the lesion size in
order to avoid damaging healthy skin cells. In order to fully understand the effects of β-
particles, continued photographic exposure experiments should be done. These experiments
should be done on thicker stacks of photographic paper and should be normalized to the
properties of skin.
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More systematic measurements are needed to fully understand and develop the skin
patch. Improving the design of the holmium radiotherapy patch so that it possesses a con-
tained, uniform deposition of holmium oxide (or holmium metal) will be necessary. These
skin patches will need to be made and predictions for their activity performed. Further
irradiations of the skin patches should be done and γ-spectra collected. Finally, the charac-
terization of the behavior of the emitted β-particles and γ-rays on the photographic paper
should be looked into further. Stacks of photographic paper of comparable thickness to
human skin should be used.
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APPENDIX A - SCHEMATICS FOR CENTERING DEVICE BASE AND CENTERING
DEVICE LADDER TOP PLATE
The schematics for the centering device base and the centering device ladder top are
shown on the next two pages. The base is shown in Figure A.1 and the top plate of the
ladder jack is shown in Figure A.2. These two parts are necessary to make accurate solid
angle measurements and keep samples at the same solid angle for γ count measurements
using the HPGe detector. The schematics were made in SolidWorks and then built in the
Colorado School of Mines physics machine shop.
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Figure A.1: The schematic for the base of the centering device is shown.
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Figure A.2: The schematic for the top plate of the centering device is shown. The top plate is attached to the top of ladder
jack.
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APPENDIX B - THE SPUTTERING PROCEDURE IS DESCRIBED FOR THE
HOLMIUM PATCHES.
The instructions for sputtering Kapton foil with holmium oxide are below. It is important
to wear gloves in all steps to avoid the contamination of the Kapton foil.
1. Place the substrate holder bottom up on to a table.
2. Take off screws with Allen wrenches. Remove metal arms.
3. Place Kapton foil and glass slide on the bottom of the substrate holder.
4. Place mask over foil.
5. Replace metal arms and screws.
The sputtering procedure used is as follows:
1. Open argon and oxygen gas supplies. Do not supply to sputtering chamber yet.
2. Make sure the load arm is pulled all the way out of the chamber and gate valve 1 is
closed.
3. Turn off the load lock vacuum. This allows the load chamber to come to atmosphere
and be opened.
4. Take lid off of load chamber and place substrate holder bottom down on the horizontal
arm. The screws around the circumference of the substrate holder fit into slots on the
horizontal arm.
5. Replace load chamber lid and turn on load chamber vacuum. Wait for chamber pressure
to reach approximately 1 · 10−6 mbar.
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6. Open gate valve 1 all the way.
7. Slide horizontal arm all the way in.
8. Bring vertical arm down to 30 mm mark.
9. Rotate vertical arm manually until notches in arm match notches in substrate holder.
10. Bring arm down to 35 mm. Rotate arm clockwise to lock arm to substrate holder.
11. Bring arm up to about 25 mm and turn on automatic substrate rotation to highest
rotation speed.
12. Make sure the substrate is not wobbling; this can affect the uniformity of the sputtering.
13. Bring vertical arm to 20 mm and remove horizontal arm. Close gate valve 1.
14. Turn on argon and oxygen gas to the sputtering chamber. Bring argon to a value of 9
and oxygen to a value of 1.
15. Bring vertical arm to 50 mm.
16. Close gate valve 2 (this is between the sputtering chamber and its pump) until sput-
tering chamber value is between 35 and 30 mTorr.
17. Turn on RF power supply.
18. Set forward power to desired power. For this experiment, 150 W is needed for sput-
tering. This is the highest the RF power supply for this particular sputtering chamber
can go without arcing. It is best to start at a lower power and slowly increase the
power to 150 W, this lets the plasma stabilize. In this case, the forward power was set
at 50 W and increased by 20 W every minute until 150 W was reached.
19. Turn on RF supply (this is a different than turning on the RF power supply). Adjust
tune and load knobs to bring reference voltage to 0 W. If voltage does not increase
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from zero, no plasma has formed. Open the target shutter until the plasma starts and
then close it.
20. Bring sputtering chamber down to 5 mTorr by opening gate valve 2.
21. Increase power every minute adjusting load and tune knobs to keep reference power
at 0 W. If the reference power starts to increase and decrease rapidly, the plasma is
arcing the RF supply should be turned off immediately.
22. Once the power is at 150 W for one minute, set a timer for the desired sputtering time.
Close viewing windows of sputtering chamber so that windows are not deposited on.
23. Open target shutter while starting timer at same time.
After sputtering time is completed:
1. Close target shutter.
2. Turn off RF supply and RF power supply.
3. Turn off substrate rotation and argon and oxygen supplies.
4. Open gate valve 2 all the way.
5. Bring arm to 20 mm. Open gate valve 1 and insert horizontal arm.
6. Bring vertical arm to 35 matching screws with horizontal arm slots.
7. Manually rotate vertical arm counterclockwise to unlock substrate holder from vertical
arm.
8. Raise arm to 20 mm. Remove horizontal arm.
9. Close gate valve 1. Turn off load chamber vacuum pumps.
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10. Take out substrate holder. Be careful, the substrate holder may be hot from being
sputtered.
11. Put lid back on load chamber and turn on vacuum, this is the way the sputtering
device should be left.
12. Remove samples from substrate holder.
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APPENDIX C - IRRADIATION AND DEVELOPMENT OF PHOTOGRAPHIC FILM.
The instructions for irradiating and developing photographic film are discussed below.
1. The exposures must be done in a dark room. The solutions (developer, stop bath,
fixer, and rinse) should be set up in containers so the paper can be submerged in them.
2. Once the room is dark, the paper may be removed from its package. The paper has
notches in one of the corners, when these are in the upper right corner the emulsion is
face up. This is the side that you want to face the holmium patch.
3. The holmium patches are placed face up onto an aluminum board and the photographic
paper is placed on top of the holmium patches with the emulsion side on top of the
holmium patches. As soon as the photographic paper is placed on top of the holmium
patches a timer is started.
4. Another aluminum board is placed on top of the stack of photographic paper and
screwed down to keep the paper from shifting.
5. Once the dose time is completed, the photographic paper should be lifted from the
holmium patches.
6. Developing the photographic paper is the next step. Although all the steps are timed,
the most important step to be timed accurately is the amount of time that the paper is
in the developer. If the papers are in the developer for different amounts of time, this
can affect the outcomes of the photographic paper. Some may appear to have received
higher doses from the radiation because they were left in the developer longer than a
paper that really received a higher dose rate but was not in the developer as long. For
this experiment, the photographic paper remains in the developer for 3 minutes.
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7. After 3 minutes, the photographic paper is put into the stop bath for 30 seconds. The
stop bath halts the developer chemical process.
8. The photographic paper is then placed into the fixer for 3 minutes. It is important
that when the paper is being developed that the fixer does not get mixed into the
developer. This can ruin the developer and give inconsistent results.
9. The photographic paper is then placed in the rinse (water) for as much time as wanted.
The rinse removes any lingering chemicals and leaving the photographic paper in for
different amounts of time does not affect the results.
10. The photographic papers can then be hung up to dry. If wanted, the drying process
can be expedited by using a low power blow dryer.
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APPENDIX D - PHOTOGRAPHIC PAPER EXPOSED TO 166HO RADIOTHERAPY
PATCHES
Are the exposures done with the photographic paper where Figure D.1 was the photo-
graphic paper closest to the radiotherapy patch and Figure D.9 was the photographic paper
farthest away. The contamination can be clearly seen in Figure D.1, Figure D.2, Figure D.3,
Figure D.4, Figure D.5, and Figure D.6. The visibility of the contamination decreases rapidly
and is difficult to see in the next films. Figure D.7, Figure D.8, and Figure D.9 show bet-
ter the geometry of the deposition. The edges of the square edge in the prototype patches
becomes visible in the last few films.
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Figure D.1: The photographic paper that was placed nearest to the irradiated holmium
patches. Contamination can be seen quite dramatically in the lower samples, and to a
lesser extent in the top samples.
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Figure D.2: The photographic paper that was placed behind the paper closest to the
irradiated holmium patches. Contamination can be seen quite dramatically in the lower
samples, a lessening of the contamination is seen as the photographic paper attenuates the
β-particles.
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Figure D.3: The next piece of photographic paper placed on top of the stack.
Contamination can still very noticeable but is less due to to attenuation.
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Figure D.4: The next piece of photographic paper placed on top of the stack.
Contamination can still very noticeable but is less due to to attenuation.
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Figure D.5: The next piece of photographic paper placed on top of the stack.
Contamination can still very noticeable but is less due to to attenuation.
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Figure D.6: The next piece of photographic paper placed on top of the stack.
Contamination can still very noticeable but is less due to to attenuation.
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Figure D.7: The next piece of photographic paper placed on top of the stack.
Contamination can still be seen but is considerably less due to to attenuation.
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Figure D.8: The next piece of photographic paper placed on top of the stack.
Contamination can still be seen but is considerably less due to to attenuation.
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Figure D.9: The next piece of photographic paper placed on top of the stack.
Contamination is almost impossible to see at this point.
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APPENDIX E - CONTOUR PLOTS FROM DENSITOMETER MEASUREMENTS OF
EXPOSED PHOTOGRAPHIC PAPER
The following contour plots were made using Mathematica. The maximum and minimum
measurements can be found for each plot in Table 4.4. Figure E.1 shows a contour plot with
10 points measured using the densitometer. Figure E.2 and Figure E.3 are contour plots
with seven points measured using the densitometer. Figure E.3, Figure E.4, Figure E.5,
Figure E.6, Figure E.7, Figure E.8, and Figure E.9 show the shadowing effects of the radiation
continue all the way through the thickness of photographic paper.
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Figure E.1: The contour plot of the densitometer measurements of exposure 1. The x and
y positions indicate an arbitrary position, because the actual measurements between points
were not taken. Instead they show a general positional relation between the outside
densitometer measurements and the central densitometer measurements.
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Figure E.2: The contour plot of the densitometer measurements of exposure 2. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.3: The contour plot of the densitometer measurements of exposure 3. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.4: The contour plot of the densitometer measurements of exposure 4. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.5: The contour plot of the densitometer measurements of exposure 5. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.6: The contour plot of the densitometer measurements of exposure 6. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.7: The contour plot of the densitometer measurements of exposure 7. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.8: The contour plot of the densitometer measurements of exposure 8. The x and
y positions indicate the same meaning as in Figure E.1 .
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Figure E.9: The contour plot of the densitometer measurements of exposure 9. The x and
y positions indicate the same meaning as in Figure E.1 .
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